Skip to main content
Fig. 1 | Trials

Fig. 1

From: Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial

Fig. 1

The study flow chart shows the two stage screening with 1) centrally approved histology and CT or MRI staging and 2) FDG-PET/CT as well as the further stratification and follow up

Back to article page

Trials

ISSN: 1745-6215